[Federal Register: August 9, 2004 (Volume 69, Number 152)]
[Notices]
[Page 48247-48249]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr09au04-76]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Statement of Organization, Functions, and Delegations of
Authority
Part C (Centers for Disease Control and Prevention) of the
Statement of Organization, Functions, and Delegations of Authority of
the Department of Health and Human Services (45 FR 67772-76, dated
October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as
amended most recently at 69 FR 17166-17167, dated April 1, 2004) is
amended to reorganize the Division of Parasitic Diseases, National
Center for Infectious Diseases.
Section C-B, Organization and Functions, is hereby amended as
follows:
Delete in its entirety the functional statement for the Division of
Parasitic Diseases (CRS) and insert the following:
Division of Parasitic Diseases (CRS). (1) Conducts surveillance,
investigations, and studies of parasitic diseases to define disease
etiology, mode of transmission, and populations at risk and to develop
effective methods for diagnosis, prevention, control, and elimination;
(2) conducts or participates in clinical, field, and laboratory
research to develop, evaluate, and improve laboratory methodologies and
materials and therapeutic practices used for rapid and accurate
diagnosis and treatment of parasitic diseases; (3) provides epidemic
aid and epidemiologic consultation, upon request, to State and local
health departments, other Federal agencies, and national and
international health organizations; (4) provides reference/diagnostic
services for parasitic diseases to State and local health departments,
other Federal agencies, and national and international health
organizations; (5) conducts a program of research and development in
the biology, ecology, host-parasitic relationships, and control of
parasitic diseases; (6) conducts laboratory studies of selected
parasitic infections, emphasizing animal models and in vitro systems
for parasitic relationships, chemotherapy, and immunology, to develop
effective methods for diagnosis, prevention, and
[[Page 48248]]
control; (7) provides scientific and technical assistance to other
components within NCID or CDC when the work requires unique expertise
or specialized equipment not available in other NCID or CDC components;
(8) provides intramural and extramural technical expertise and
assistance in professional training; (9) serves as World Health
Organization (WHO) Collaborating Centers for Cysticercosis, Research
Training and Control of Dracunculiasis, Control and Elimination of
Lymphatic Filariasis, Evaluating and Testing New Insecticides,
Insecticide Resistance, Insect Vectors; Malaria Control in Africa,
Human African Trypanosomiasis, Production and Distribution of Malaria
Sporozoite ELISAs, Collaborating Centers for Eradication of Guinea
Worm; (10) maintains field-based research stations in Guatemala in
collaboration with Universidad del Valle de Guatemala, and in Kenya in
collaboration with KEMRI; (11) carries out this mission in a workplace
that promotes professional development and recognizes the importance of
the individual and the team; (12) provides communication support to
enhance overall methods of dissemination of credible information to the
public, local and state health officials, international partners and
private funders in order to inform health decisions to prevent and
control parasitic diseases in the United States and abroad. The
services are provided through the partnerships with health care
professionals, state, local and federal agencies with the United
States, foreign governments, national and international organizations,
and the public.
Delete in its entirety the functional statement for the Data
Management Activity (CRS-2) and insert the following:
Data Management Activity (CRS12). (1) Provides statistical and
information systems consultation for study design and protocol
development; (2) designs and implements database management systems
(including geographic information systems) in support of the Division
of Parasitic Diseases (DPD) projects; (3) provides data analysis and
statistical consultations in support of DPD projects; develops new
methodologies as needed; (4) assists in production of and provides
graphics support for presentations and manuscripts related to DPD
objectives; (5) evaluates new software for statistical analysis,
database management, graphics production, map creation, geographical
information systems, and other functions related to DPD objectives and
provides support for division activities in these areas.
Delete the title and functional statement for the Parasitic
Diseases Epidemiology Branch (CRS2) and insert the following:
Parasitic Diseases Branch (CRS2). (1) Investigates outbreaks and
unusual occurrences of parasitic diseases when requested by State
departments, ministries of health, the World Health Organization (WHO),
and other agencies and organizations; (2) conducts surveillance of
waterborne disease outbreaks and other parasitic diseases in the United
States; (3) provides reference and laboratory diagnostic services to
physicians and laboratories; (4) transfers technologies and expertise
in laboratory diagnosis of parasitic infections to public health
laboratories; (5) provides consultation on the treatment and management
of parasitic diseases to clinicians, laboratorians, departments of
health, and other agencies; (6) provides otherwise unavailable anti-
parasitic drugs to healthcare providers and ensures compliance with the
Food and Drug Administration's regulations; (7) provides leadership and
technical expertise in support of the agency's bioterrorism
preparedness response initiatives as they relate to waterborne venues;
(8) supports the agency's overall emergency response mandate; (9)
conducts research on methods to detect parasites and agents of
bioterrorism in water, and developing emergency public health response
plans; (10) conducts field and laboratory investigations and research
on the etiology, biology, epidemiology, ecology, pathogenesis,
immunology, genetics, host-parasitic relationships, chemotherapy and
other aspects of parasitic diseases to develop new tools for
identifying and controlling parasitic diseases; (11) develops and tests
new laboratory methods and tools for improved diagnosis, control, and
prevention of parasitic diseases; (12) evaluates current strategies and
develops new strategies for the control and elimination of parasitic
diseases; (13) carries out and evaluates operational research to
support programmatic activities; (14) provides technical assistance to
ministries of health, the World Health Organization, and other agencies
and organizations for these programs; (15) plans, implements and
evaluates such programs; (16) provides training to EIS officers,
Emerging Infectious Disease Fellow, AMS/NCID Postdoctoral Fellows,
Preventive Medicine Residents, Public Health Prevention Specialists,
and other fellows and students; (17) prepares educational materials on
the prevention and treatment of parasitic diseases; (18) conducts
laboratory training courses for public health laboratories; (19)
prepares and disseminates health communication materials.
Delete in its entirety the functional statement for the Entomology
Branch (CRS3) and insert the following:
Entomology Branch (CRS3). (1) Conducts laboratory and field
research to develop, evaluate, and implement effective surveillance and
vector arthropod control strategies; (2) develops and utilizes
analytical methods for the use of pesticides for the control of vector-
borne diseases, identification and quantification of anti-parasitic
drugs, pharmaceutical products, and their metabolites in body fluids
and tissues of humans and other animals; (3) serves as a WHO
Collaborating Center or as an international standardized reference
reagent and vector repository for methods development, training,
surveillance, and research for insecticide resistance, vector
identification, antimalarial drug evaluation, host-vector
relationships, vector control; (4) provides entomological consultation
and training to local, State, foreign and international health
organizations on surveillance and control of vectors and vector-borne
diseases; (5) conducts studies or collaborates on other disease
surveillance and control initiatives as needed.
Delete in their entirety the title and functional statement for the
Biology and Diagnostics Branch (CRS4).
Delete in their entirety the title and functional statement for the
Immunology Branch (CRS5).
Delete in its entirety the title and functional statement for the
Malaria Epidemiology Branch (CRS6) and insert the following:
Malaria Branch (CRS6). (1) Conducts malaria surveillance,
prevention, and control in U.S. residents and visitors, including
monitoring the frequency and distribution of malaria cases that occur
in U.S. residents and visitors; monitoring the efficacy and safety of
antimalarial drugs for chemoprophylaxis and chemotherapy; offering
clinical advice and epidemiologic assistance on the treatment, control,
and prevention of malaria in the United States and in malaria endemic
countries; and providing information to the U.S. public and to agencies
or groups serving this population on appropriate measures to prevent
and control malaria; (2) provides consultation, technical assistance,
and training to malaria-endemic countries and to international and
United States agencies and
[[Page 48249]]
organizations on issues of malaria prevention and control; (3) conducts
epidemiologic, laboratory, and field-based research projects, in
support of Malaria Branch mandates (1 and 2 above),
including laboratory and field studies on parasitic diseases to define
biology, ecology, transmission dynamics, parasite species differences,
host-parasite relationships, diagnostics, host immune responses,
populations at risk, and determinants of morbidity and mortality; (4)
conducts laboratory studies of malaria parasites, emphasizing animal
models and in vitro systems for parasitic relationships, chemotherapy,
and vaccine evaluation studies; (5) conducts field studies of malaria
prevention and control tools and strategies; (6) conducts assessments
of malaria monitoring and evaluation methods and program use of these
methods.
Dated: July 27, 2004.
William H. Gimson,
Chief Operating Officer, Centers for Disease Control and Prevention
(CDC).
[FR Doc. 04-18072 Filed 8-6-04; 8:45 am]
BILLING CODE 4160-18-M